Skip to main content
. Author manuscript; available in PMC: 2017 Jul 15.
Published in final edited form as: Clin Cancer Res. 2016 Mar 30;22(14):3488–3498. doi: 10.1158/1078-0432.CCR-15-2290

Figure 4. Kaplan-Meier recurrence-free survival for the pooled population of T3, pMMR, chemo-naive stage II colon cancer patients according to the GIV/LVI risk classifier and clinical (‘All Clin’) model.

Figure 4

(A) Comparative survival stratification for the entire followup perior, and (B) detailed view for the first three years. While the GIV/LVI stratification is shown for all cohorts pooled, the clinical model does not include cases from the independent validation set due to missing lymph node yield data.